Search Results - "refractory/relapsed"

Acalabrutinib in Chinese patients with relapsed/refractory chronic lymphocytic leukemia: Primary analysis from an open-label, multicenter phase 1/2 trial

Yang, Shenmiao, Huang, Haiwen, Zhou, Keshu, Zhao, Xielan, Han, Yanqiu, Li, Lindong, Wang, Yujie, Liu, Xiaofeng, Li, Jianyong^{Aff7, Aff8, IDs00277024059784_cor1}

Complete loss of lineage defining antigens in two cases of B-cell malignancies following CAR-T therapy

Torabi, Alireza^{Aff1, IDs1230802400602w_cor1}, Love, Jason, Hyun, Teresa, Pham, Angie, Gauthier, Jordan^{Aff4, Aff5}, Hirayama, Alexandre^{Aff4, Aff5}, Wu, David, Naresh, Kikkeri^{Aff1, Aff2}

A phase 1b/2 study evaluating efficacy and safety of MP0250, a designed ankyrin repeat protein (DARPin) simultaneously targeting vascular endothelial growth factor (VEGF) and hepatocyte growth factor (HGF), in combination with bortezomib and dexamethasone, in patients with relapsed or refractory multiple myeloma

Stefan Knop, Monika Szarejko, Norbert Grząśko, Sara Bringhen, Karolin Trautmann‐Grill, Artur Jurczyszyn, Angelo Vacca, Cyrus Khandanpour, Barbara Gamberi, Ludek Pour, Katrine F. Iversen, Michael T. Stumpp, Cosima Suter, Keith M. Dawson, Christof Zitt, Philippe Legenne, Vaia Stavropoulou, Martin F. Fey, Nicolas Leupin, Hartmut Goldschmidt

electronic resource

View item

Rapid identification of early infections in febrile patients after CD19 target CAR-T cell therapy for B-cell malignancies

Pu, Lian-Fang^{Aff1, Aff2}, Zheng, Hui-Min^{Aff1, Aff2}, Feng, Xiang-Jiang^{Aff1, Aff2}, Charwudzi, Alice, Liang, Xue^{Aff1, Aff2}, Hu, Lin-Hui^{Aff1, Aff2}, Ding, Yang-Yang^{Aff1, Aff2}, Liu, Ze-Lin^{Aff1, Aff2}, Liao, Ya^{Aff1, Aff2}, Xiong, Shu-Dao^{Aff1, Aff2, Aff4, IDs12967024053082_cor10}

Diversifying the anthracycline class of anti-cancer drugs identifies aclarubicin for superior survival of acute myeloid leukemia patients

Qiao, Xiaohang^{Aff1, Aff2, IDs12943024020347_cor1}, van der Zanden, Sabina Y., Li, Xiaoyang, Tan, Minkang, Zhang, Yunxiang, Song, Ji-Ying, van Gelder, Merle A., Hamoen, Feija L., Janssen, Lennert, Zuur, Charlotte L.^{Aff1, Aff2}, Pang, Baoxu, van Tellingen, Olaf, Li, Junmin^{Aff4, Aff7, IDs12943024020347_cor13}, Neefjes, Jacques^{Aff3, IDs12943024020347_cor14}

A viral infection prediction model for patients with r/r B-cell malignancies after CAR-T therapy: a retrospective analysis

Shujing Guo, Jile Liu, Bing Wang, Xiaomei Zhang, Yifan Zhao, Jianmei Xu, Xinping Cao, Mohan Zhao, Xia Xiao, Mingfeng Zhao

electronic resource

View item; View item

Combination autologous stem cell transplantation with chimeric antigen receptor T-cell therapy for refractory/relapsed B-cell lymphoma: a single-arm clinical study

Danyang Li, Rui Liu, Zhonghua Fu, Fan Yang, Lixia Ma, Yuelu Guo, Miaomiao Cao, Yang Lei, Yimeng Dou, Xuenan Zhang, Yan Gao, Bian Wei, Biping Deng, Xiaoyan Ke, Kai Hu

electronic resource

View item; View item

Efficacy and safety of zanubrutinib combined with chimeric antigen receptor T-cell therapy targeting CD19 in refractory or relapsed diffuse large B cell lymphoma: A retrospective analysis

Jinhuan Xu, Xiaoying Zhang, Yun Li, Fankai Meng, Yicheng Zhang, Miao Zheng

electronic resource

View item; View item

Incidentally cured psoriasis in a patient with refractory/relapsed diffuse large B-cell lymphoma receiving CD19 CAR-T cell therapy: a case report

Song-yun Wang, Wan-hua An, Ze-song Wang, Wan-li Wang, Bin Zhang, Kai-lin Xu, Shu-li Guo, Ming Gao, Bo Li, Lei Huang, Huan-huan Tian, Wen-yi Guo, Hui-rui Wang

electronic resource

View item; View item

Gilteritinib combined with venetoclax and azacitidine for relapsed acute myeloid leukemia cocurrent with pure red cell aplasia after allogeneic hematopoietic stem cell transplantation: a case report

Wang, Jiawen, Zhu, Han, Miao, Kourong^{Aff1, IDs0027702405714y_cor3}

CLAG combined with total body irradiation as intensive conditioning chemotherapy prior to allogeneic hematopoietic stem cell transplantation in patients with refractory or relapsed acute myeloid leukemia

Fei, Xinhong, Zhang, Weijie, Gu, Jiangying, Yang, Fan, Li, Tingting, Wang, Wenjing, Wang, Jingbo^{Aff1, IDs00277023055020_cor7}

Efficacy and Safety of Dual-targeted Chimeric Antigen Receptor-T Cell Therapy in Patients with Refractory-relapsed Multiple Myeloma: a Meta-analysis

YU Haibo, ZHANG Tianyu, LI Xin, ZHANG Jiajia, SHEN Man, ZHAN Xiaokai, TANG Ran, FAN Sibin, ZHAO Fengyi, HUANG Zhongxia

electronic resource

View item; View item

Preliminary exploration of PSMA CAR-T combined with GD2 CAR-T for the treatment of refractory/relapsed gliomas

Gu, Jinshan^Aff1, Li, Jiasheng^Aff2, Xu, Yang, Zhang, Ge, Xie, Jingyi, Jia, Rui, Chen, Wei, Lu, Zhengfeng, Chang, Chengwei, Wen, Haijun, Chang, Lung-ji^{Aff3, IDs12967025065231_cor1}, Ma, Huajuan^{Aff1, IDs12967025065231_cor2}, Cai, Qichun^{Aff1, IDs12967025065231_cor3}

Isatuximab in the treatment of refractory and relapsed multiple myeloma: literature review and case report

Yu. E. Ryabukhina, P. A. Zeynalova, F. M. Abbasbeyli, O. L. Timofeeva, T. T. Valiev, N. A. Kupryshina, A. G. Zhukov

electronic resource

View item; View item; View item

Elotuzumab in the treatment of patients with refractory and relapsed multiple myeloma Experience of the Lapino Clinical Hospital Oncohematology Department

Yu. E. Ryabukhina, P. A. Zeynalova, F. M. Abbasbeyli, O. L. Timofeeva, N. A. Kupryshina, T. T. Valiev

electronic resource

View item; View item; View item

A CAR-T response prediction model for r/r B-NHL patients based on a T cell subset nomogram

Zhang, Xiaomei, Sun, Rui, Zhang, Meng, Zhao, Yifan, Cao, Xinping, Guo, Ruiting, Zhang, Yi, Liu, Xingzhong, Lyu, Cuicui^{Aff2, IDs0026202303618w_cor9}, Zhao, Mingfeng^{Aff2, IDs0026202303618w_cor10}

Anti‐CLL1‐based CAR T‐cells with 4‐1‐BB or CD28/CD27 stimulatory domains in treating childhood refractory/relapsed acute myeloid leukemia

Kunlin Pei, Haoyu Xu, Pengfei Wang, Wening Gan, Zhengbin Hu, Xiaoling Su, Hui Zhang, Yingyi He

electronic resource

View item

Sirolimus is effective for primary refractory/relapsed warm autoimmune haemolytic anaemia/Evans syndrome: a retrospective single-center study

Zhuxin Zhang, Qinglin Hu, Chen Yang, Miao Chen, Bing Han

electronic resource

View item; View item

Daratumumab plus bortezomib or daratumumab plus lenalidomide as salvage therapy for patients with myeloma: initial follow-up of an Italian multicentre retrospective clinical experience by ‘Rete Ematologica Pugliese’

Mele, G.^{Aff1, IDs00277022048570_cor1}, Cascavilla, N., Di Renzo, N., Guarini, A., Mazza, P., Melillo, L., Pavone, V., Tarantini, G., Curci, P., Falcone, A. P., Germano, C., Mele, A., Palazzo, G., Palumbo, G., Reddiconto, G., Rossini, B., Specchia, G., Musto, P., Pastore, D.

Modern approaches to the treatment of relapsed follicular lymphoma

Yu. E. Ryabukhina, F. M. Abbasbeyli, P. A. Zeynalova, O. L. Timofeeva, A. F. Batsev, G. F. Allakhverdieva, O. V. Sinitsina, A. G. Zhukov

electronic resource

View item; View item; View item